SCHEMBL19786334

SCHEMBL19786334

c1ccc(-c2nc(-n3c4ccccc4c4c5c6ccc7ccccc7c6oc5c5ccccc5c43)nc3oc4ccccc4c23)cc1

nearest known ligand 0.31

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.31
CYP1A1 P04798 2/20 0.31
CYP1A2 P05177 2/20 0.31
CYP1B1 Q16678 2/20 0.31
ABCC1 P33527 2/20 0.31
KDM4E B2RXH2 1/20 0.31
PDE5A O76074 1/20 0.31
ALDH1A1 P00352 1/20 0.31
TP53 P04637 1/20 0.31
ABCB1 P08183 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
MAPT P10636 1/20 0.31
CYP19A1 P11511 1/20 0.31
CYP2C9 P11712 1/20 0.31
HPGD P15428 1/20 0.31
TSHR P16473 1/20 0.31
CYP2B6 P20813 1/20 0.31
TACR2 P21452 1/20 0.31
TBXAS1 P24557 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19786325 0.85 ALDH1A1 (0.41) ABCG2CYP1A1CYP1A2CYP1B1ABCC1
SCHEMBL19786685 0.84 CYP1A1 (0.33) ABCG2CYP1A1CYP1A2CYP1B1ABCC1
SCHEMBL19046678 0.84 SMN1; SMN2 (0.34) CYP1A2KDM4EALDH1A1MAPTCYP2C9
SCHEMBL19786612 0.84 SMN1; SMN2 (0.37) CYP1A2ALDH1A1CYP2C9HPGDMAPK1
SCHEMBL19246261 0.83 MEN1 (0.36) CYP1A2ALDH1A1MAPTCYP2C9HPGD
SCHEMBL19786324 0.83 CYP1A1 (0.36) ABCG2CYP1A1CYP1A2CYP1B1ABCC1
SCHEMBL19246321 0.83 SMN1; SMN2 (0.37) CYP1A2KDM4EALDH1A1MAPTCYP2C9
SCHEMBL19679711 0.83 MEN1 (0.33) ABCG2CYP1A1CYP1A2MAPTTDP1
SCHEMBL22011380 0.82 MEN1 (0.33) CYP1A2ALDH1A1MAPTCYP2C9LMNA
SCHEMBL19163142 0.81 TDP1 (0.30) TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2019-10-03 US disclosed
WO-2018012781-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF ORC3, OR51E2, ORAI2 ABCG2 4645/4885CYP1A1 3556/4885CYP1A2 2971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.